Disease mechanisms as Subtypes: Mitochondrial and bioenergetic dysfunction-Reference-Cited by-同舟云学术

Disease mechanisms as Subtypes: Mitochondrial and bioenergetic dysfunction

Published:2023 Issue: Volume: Page:53-66
ISSN:0072-9752
Container-title:Handbook of Clinical Neurology
language:
Short-container-title:

Author:

Gonzalez-Rodriguez Patricia,Zampese Enrico,Surmeier D. James

Publisher

Elsevier

Reference157 articles.

1. Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction?;Ahlskog;Neurology,2010

2. The functional anatomy of basal ganglia disorders;Albin;Trends Neurosci,1989

3. Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine;Anekonda;Biochim Biophys Acta,2011

4. Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism;Asanuma;Acta Med Okayama,2004

5. Ionic mechanisms underlying autonomous action potential generation in the somata and dendrites of GABAergic substantia nigra pars reticulata neurons in vitro;Atherton;J Neurosci,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates;npj Parkinson's Disease;2024-06-17

2. Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients;CNS & Neurological Disorders - Drug Targets;2024-05

3. Aging and Parkinson’s disease: a complex interplay of vulnerable neurons, the immune system and the blood-brain barrier;Ageing and Neurodegenerative Diseases;2024-03-27